Viyash Scientific Ltd share price logo

Sequent Scientific Share Price

NSE: VIYASH

BSE: 512529

Small Cap

Healthcare Sector

₹212.70

+8.47

(+4.15%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

Sequent Scientific Stock Performance

as on February 3, 2026 at 4:01 pm IST

  • Day's Low

    Day's High

    ₹208.31
    ₹218.00
    downward going graph

    2.06%

    Downside

    2.49%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    ₹117.35
    ₹257.85
    downward going graph

    44.83%

    Downside

    21.23%

    Upside

    downward going graph

Sequent Scientific share price movements today

Previous Close
₹204.23
Open
₹208.50
Volume
13.44L
Upper Circuit
₹245.07
Lower Circuit
₹163.39
Day's Low - High
₹208.31 - ₹218.00
52 Week Low - High
₹117.35 - ₹257.85

Sequent Scientific Historical Returns

1 Month Return
-1.31 %
3 Month Return
-6.25 %
1 Year Return
+ 27.51 %
3 Year Return
+ 175.06 %
5 Year Return
-12.08 %

Sequent Scientific Fundamentals

as on February 3, 2026 at 4:01 pm IST

Market Cap

₹8,917.05 Cr

Return on Equity (ROE)

1.42

PE Ratio (TTM)

122.29

Return on capital employed (ROCE)

2.23

Industry PE ratio

39.84

Beta (LTM)

1.4

P/B Ratio

2.87

Dividend Yield

0

PEG Ratio

121.08

Quarterly Earnings Growth YOY

209.15

EPS (TTM)

1.29

Sector

Pharmaceuticals

Book Value

28.15

Technical Analysis

Bullish

View Technical Analysis

Sequent Scientific Stock Valuation

as on February 3, 2026 at 4:01 pm IST

Sequent Scientific in the last 5 years

  • Overview

  • Trends

Lowest (-117.80x)

January 17, 2023

Industry (39.84x)

February 2, 2026

Today (122.29x)

February 2, 2026

Highest (1034.67x)

September 27, 2024

LowHigh

Today’s Price to Earnings Ratio: 122.29x

Viyash Scientific Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Sequent Scientific with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Viyash Scientific Ltd image
Viyash Scientific Ltd
NA8,917.05-2.42%0.72321,551
Walpar Nutritions Ltd image
Walpar Nutritions Ltd
NA42.7311.93%0.69271
Orchid Pharma Ltd image
Orchid Pharma Ltd
BUY3,419.7415.73%0.5695921
Brawn Biotech Ltd image
Brawn Biotech Ltd
NA5.78-3.51%0.00-213
Medicamen Biotech Ltd image
Medicamen Biotech Ltd
NA489.89-6.91%0.576162
See all

Sequent Scientific Share Price Target

Get share price movements and forecasts by analysts on Sequent Scientific.

Source: S&P Global Market Intelligence

Sequent Scientific Stock’s Investor Sentiment and Interest

Search interest for Viyash Scientific Ltd Stock has decreased by -9% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-9% versus previous 30 day period

Viyash Scientific Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Sales
366.67
333.21
345.97
329.36
361.2
390.21
368.65
390.81
401.7
441.42
423.99
Other Income
1.74
0.79
9.72
7.28
4
2.68
4.51
5.84
1.66
3.87
2.15
Total Income
368.41
334
355.68
336.64
365.2
392.89
373.16
396.65
403.36
445.29
426.14
Expenses
431.63
364.96
330.84
307.11
333.64
348.26
333.87
356.62
355.8
390.48
370.01
Operating Profit
-64.96
-31.75
15.13
22.25
27.56
41.95
34.78
34.19
45.9
50.94
53.98
Operating Profit Margin %
-17.72%
-9.53%
4.37%
6.76%
7.63%
10.75%
9.43%
8.75%
11.43%
11.54%
12.73%
Profit Before Interest, Tax and Depreciation
-63.23
-30.96
24.85
29.53
31.56
44.63
39.29
40.03
47.56
54.81
56.13
Interest
10.87
10.48
12.58
12.58
12.44
16.38
14.29
14.95
15.13
14.16
13.51
Depreciation
14.71
14.24
15.36
15.46
16.48
16.25
17.1
16.98
16.12
15.13
15.46
Profit Before Tax
-88.81
-55.68
-3.09
1.49
2.64
12
7.9
8.1
16.31
25.52
27.16
Tax Paid
3.64
-21
3.79
-9.19
1.37
2.94
1.56
1.62
5.93
7.95
7.56
Profit After Tax
-92.44
-34.68
-6.88
10.68
1.27
9.06
6.34
6.48
10.38
17.57
19.6
Total Net profit including share of profit / Loss from associate company
-92.44
-34.68
-6.88
10.68
1.27
9.06
6.34
6.48
10.38
17.57
19.6
EPS
-3.77
-1.4
-0.34
0.33
-0.04
0.26
0.11
0.14
0.37
0.57
0.59
Actual EPS
-3.77
-1.4
-0.34
0.33
-0.04
0.26
0.11
0.14
0.37
0.57
0.59
Adjusted EPS
-3.77
-1.4
-0.34
0.33
-0.04
0.26
0.11
0.14
0.37
0.57
0.59
Diluted EPS
-3.77
-1.4
-0.34
0.33
-0.04
0.26
0.1
0.13
0.36
0.56
0.58

Viyash Scientific Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Sales
683.57
847.84
1,039.31
1,179.24
1,361.62
1,412.82
1,420.91
1,369.73
1,551.37
Other Income
11.08
446.54
8.67
10.09
8.36
10.85
6.39
10.96
14.69
Total Income
694.65
1,294.37
1,047.98
1,189.33
1,369.98
1,423.66
1,427.3
1,380.69
1,566.06
Expenses
643.15
775.67
914.37
1,008.92
1,158.37
1,303.42
1,473.75
1,325.71
1,394.55
Operating Profit
40.42
72.17
124.94
170.32
203.25
109.4
-52.84
44.02
156.82
Operating Profit Margin %
5.91%
8.51%
12.02%
14.44%
14.93%
7.74%
-3.72%
3.21%
10.11%
Profit Before Interest, Tax and Depreciation
51.5
518.7
133.61
180.41
211.61
120.25
-46.45
54.98
171.51
Interest
28.34
33.07
32.8
35.71
24.38
15.77
35.52
48.09
60.75
Depreciation
40.07
41.34
41.92
50.62
50.6
51.54
55.69
61.54
66.45
Profit Before Tax
-16.91
444.29
58.89
94.08
136.63
52.94
-137.66
-54.65
44.31
Tax Paid
-0.53
13.46
2
12.03
32.18
8.17
-15.68
-25.03
12.05
Profit After Tax
-16.39
430.83
56.88
82.05
104.45
44.76
-121.98
-29.62
32.26
Total Net profit including share of profit / Loss from associate company
-16.39
430.83
56.88
82.05
104.45
44.76
-121.98
-29.62
32.26
EPS
-0.57
-0.11
2
2.87
3.87
1.65
-4.88
-1.44
0.88
Actual EPS
-0.57
-0.11
2
2.87
3.87
1.65
-4.88
-1.44
0.88
Adjusted EPS
-0.53
-0.1
2
2.87
3.87
1.65
-4.88
-1.44
0.88
Diluted EPS
-0.57
-0.11
1.99
2.85
3.85
1.63
-4.88
-1.44
0.85

Viyash Scientific Ltd Cash Flow

Figures in Rupees Crores

Mar 2016
Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Net Cash from Operating Activities
-0.05
-7.19
45.24
116.02
115.33
114.75
30.6
16.81
30.6
83.36
Cash Flow from Investing Activities
-244.92
-37.44
54.18
-67.7
-72.27
9.64
-94.09
-64.96
-5.93
-24.78
Cash Flow from Financing Activities
308.69
147.44
-56.97
-20.1
-42.75
-138.76
67.25
32.22
-1.45
-60.73
Net Cash Flow
-1.82
24.07
-4.55
28.25
0.31
-14.35
3.75
-15.92
23.24
-2.15

Sequent Scientific Stock Shareholding Pattern

Numbers in percentages

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Promoters
52.79%
52.79%
52.79%
52.79%
52.79%
52.78%
52.76%
52.61%
52.61%
52.61%
52.33%
61.41%
DII
2.92%
2.92%
3.23%
5.02%
7.59%
8.06%
9.99%
12.02%
12.82%
12.98%
12.91%
7.36%
FII
0%
0%
6.03%
0%
6.16%
5.7%
6.45%
6.1%
6.05%
6.15%
5.91%
3.16%
Public
38.01%
37.64%
37.57%
33.7%
33.29%
33.3%
30.63%
29.11%
28.36%
28.1%
28.69%
27.97%
Total Outstanding Shares
24,94,33,495
24,94,33,495
24,94,33,495
24,94,33,495
24,94,33,495
24,94,80,995
24,95,81,995
25,03,01,995
25,03,01,995
25,03,04,995
25,16,52,648
43,61,34,476
Total Shareholders
1,91,875
1,87,474
1,84,521
1,72,853
1,66,593
1,63,693
1,54,603
1,62,574
1,58,152
1,47,320
1,44,085
1,34,194

Mutual Funds that own Sequent Scientific Stock

Check out the Mutual Funds with significant holdings in Sequent Scientific.

Sequent Scientific Corporate Actions

View detailed summary of the earnings and dividend history of Sequent Scientific.

  • Viyash Scientific Ltd Earnings Results

    Viyash Scientific Ltd’s net profit jumped 464.75% since last year same period to ₹14.74Cr in the Q2 2025-2026. On a quarterly growth basis, Viyash Scientific Ltd has generated 3% jump in its net profits since last 3-months.

    Read More about Earnings Results

  • Viyash Scientific Ltd Dividends June,2021

    In the quarter ending March 2021, Viyash Scientific Ltd has declared dividend of ₹0.50 per share on 30 Jun 2021 - translating a dividend yield of 0.24%.

    Read More about Dividends

Indices Featuring Sequent Scientific Stock

Check stock indices that include Sequent Scientific.

BSE Healthcare

₹42,253.02

2.83 (▲1164.07%)

Insights on Viyash Scientific Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, SEQUENT has outperformed top 5 stocks with highest market-cap in Pharmaceuticals

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, SEQUENT has outperformed top 5 stocks with highest market-cap in Pharmaceuticals

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 6 months, SEQUENT stock has moved up by 18.3%

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 4 quarters, 373.16 Cr → 445.29 Cr (in ₹), with an average increase of 5.7% per quarter

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 4 quarters, 2.61 Cr → 14.31 Cr (in ₹), with an average increase of 40.7% per quarter

  • imgPOSITIVE IMPACT

    Retail Holding Up

    img

    Retail Investor have increased holdings from 28.10% to 28.69% in Sep 2025 quarter

  • imgNEGATIVE IMPACT

    Promoter Holding Down

    img

    Promoters have decreased holdings from 52.61% to 52.33% in Sep 2025 quarter

  • imgNEGATIVE IMPACT

    MF Holding Down

    img

    Mutual Funds have decreased holdings from 10.08% to 10.04% in Sep 2025 quarter

  • imgNEGATIVE IMPACT

    FII Holding Down

    img

    Foreign Institutions have decreased holdings from 6.15% to 5.91% in Sep 2025 quarter

About Viyash Scientific Ltd

Visistha Traders Finance Ltd has combined itself with PI Drugs and Pharmaceuticals Ltd. Confirmation of amalgamation was approved by the High Court on November 12th 2003. As a result, one of the leading companies in the Indian pharmaceutical industry is now under its wing. It is anticipated that the move will benefit both the companies, shareholders and society at large. It will help Visistha Traders further solidify its creative and enterprising portfolio while aiding PI Drugs expand its reach and customer base. The amalgamation will make it easier to access the required resources, human and capital in a more efficient manner. Another positive factor of this step is that it will reduce administrative costs, allowing for a more productive use of resources. Combining the skill sets of both firms also ensures the sector benefits the most efficient and cutting-edge solutions. All in all, this is a step that is expected to lead to a brighter future for the pharmaceutical sector.

Revenue: ₹423.99Cr as on September 2025 (Q2 FY26)
Net Profit: ₹19.60Cr as on September 2025 (Q2 FY26)
Listing date: 10 Mar, 2016
Chairperson Name: Kamal K Sharma
OrganisationViyash Scientific Ltd
HeadquartersBangalore
IndustryPharmaceuticals
CEOKamal K Sharma
E-voting on sharesClick here to vote

FAQs

What is Sequent Scientific share price today?

Sequent Scientific share price today stands at ₹212.7 as on at the close of the market. Sequent Scientific share today touched a day high of ₹218 and a low of ₹208.31.

What is the 52 week high and 52 week low range for Sequent Scientific share?

Sequent Scientific touched a 52 week high of ₹257.85 and a 52 week low of ₹117.35. Sequent Scientific share price today i.e. is closed at ₹212.7, which is -17.51% down from its 52 week high and 81.25% up from its 52 week low.

What is Sequent Scientific's market capitalisation today?

Sequent Scientific market capitalisation is ₹8,917.05 Cr as on .

How to buy Sequent Scientific shares?

To buy Sequent Scientific shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for VIYASH or Viyash Scientific Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Sequent Scientific shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Sequent Scientific trading volume today?

Sequent Scientific trading volume is 13.44L as on . This means that 13.44L shares of Sequent Scientific were bought and sold on the stock market during today's trading session.